Sherwood ER, Williams DL. Reversal of sepsis-induced T cell dysfunction: OX-40 to the rescue? Journal of leukocyte biology. 2020 Sep 29. PMID: 32991749 [PubMed]
The study of Unsinger and colleagues provide important insights into OX40 mediated immunotherapy as a potential approach for the treatment of sepsis induced immune suppression.